江南化工(002226.SZ):紫南投資累計減持1.04%股份
格隆匯7月2日丨江南化工(002226.SZ)公佈,近日,公司收到5%以上股東紫金礦業紫南(廈門)投資合夥企業(有限合夥)(簡稱“紫南投資”)出具的《關於權益變動觸及1%整數倍的告知函》,獲悉,紫南投資於2025年5月23日至2025年7月1日通過集中競價及大宗交易方式累計減持公司股份27,599,057股,佔公司總股本的1.04%。紫南投資與紫金礦業投資(上海)有限公司(以下簡稱“紫金投資”)作爲一致行動人合計持有公司股份比例從21.81%下降至20.77%,權益變動觸及1%刻度的整數倍。截至目前,本次減持計劃尚未實施完畢,紫南投資將繼續實施減持計劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.